236 Studies Now Enrolling
Menu
Search
Status
Medical Condition
- Show all (299)
- Addiction (4)
- Autoimmune Disorders (1)
- (-) Blood Disorders (1)
- Cancer (27)
- COVID-19 (Coronavirus) (1)
- Ear, Nose and Throat (3)
- Endocrine & Metabolic Disease (1)
- Eye (1)
- Healthy Volunteers (42)
- Heart Disease (1)
- Infectious Disease (2)
- Neurological Disorders (165)
- Obesity (1)
- Obstetrics & Gynecology (3)
- Pediatrics (10)
- Psychiatric Disorders (31)
- Rehabilitation (1)
- Stroke (1)
- Transplant (2)
- Vascular Conditions (1)
Displaying 1 - 2 of 2
Condition: Autoimmune Disorders / Lupus
Investigator: Anca Askanase, MD, MPH
Status: Closed
This study is for patients who have been diagnosed with systemic Lupus erythematosus (SLE). SLE is a disease in which the body mistakenly attacks healthy tissue. It can affect the skin, joints, kidneys, brain and other organs. The purpose of this study is to test the effects of an investigational (being tested) study drug, CC…
Condition: Blood Disorders / Amyloidosis
Investigator: Thomas Brannagan, MD
Status: Closed
HELIOS-A is a global Phase 3 randomized, open-label study designed to evaluate the safety and efficacy of ALN-TTRSC02 in adult patients with hATTR amyloidosis experiencing neurologic symptoms brought on by the disease. The study will also evaluate any changes in quality of life experienced by study participants. ALN-TTRSC02 utilizes the mechanism of RNA…